Comparison of Three Different Pain and Anxiety Reducing Methods in Adult Patients Undergoing Bone Marrow Puncture

Phase 4

Completed

• Conditions: Patients Undergoing Puncture of the Bone Marrow

• Registration Number: NCT00188227
• Lead Sponsor: Technische Universität Dresden

Brief Summary

The purpose of this study is to investigate and compare the effects of three different methods for reducing pain and anxiety in adult patients undergoing puncture of the bone marrow. The investigated methods are: cognitive behavioural technique, administration of a sedative drug(Midazolam) and administration of an analgetic drug (Piritramid)prior to the procedure. Additionally, there are two comparison groups in which the patients receive either placebo treatment or no treatment at all.

Detailed Description

The puncture of the bone marrow is a routine medical procedure which is often performed in the field of hematology/oncology. When carefully and appropriately performed, the puncture of the bone marrow has a very low rate of complications and is generally safe for the patient. However, it is an invasive and painful procedure associated with anxiety, especially in patients undergoing repeated punctures. Therefore an appropriate preparation of the patient for the puncture is essential in order to minimize the stress experienced during the procedure. In this regard, there are numbers of both pharmacological and non-pharmacological interventions in pedriatric patients aimed at reducing the punction related pain and anxiety in this patients. Nevertheless an evidence based approach for the pretreatment of the patients is yet to be established. The aim of this study is to investigate three different methods for reducing the pain and anxiety associated with the puncture of the bone marrow in adult patients. Two of the of the investigated methods involve pretreatment of the patients with pharmacological agents (sedative drug or analgetic drug), whereas the third method involves cognitive behavioural pretreatment in form of an audio material. The patients in the control group receive placebo injections.

Study Timeline

• Study Start: 2001-09
• Study Completion: 2003-11
• Status Verified: 2005-09
• Study First Submitted: 2005-09-10
• Study First Submitted QC: 2005-09-10
• Study First Posted: 2005-09-16
• Last Update Submitted: 2007-04-19
• Last Update Posted: 2007-04-20

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 748

Inclusion Criteria

• Patients scheduled for both first or repeated punction of the bone marrow
• Age between 18 and 85 years
• Written informed consent

Exclusion Criteria

• Contraindication for a punction of the bone marrow
• Administration of benzodiazepines or analgetic drugs prior to the bone marrow punction
• Known hypersensitivity to benzodiazepines or Piritramid
• Known contraindication to benzodiazepines (Myasthenia gravis in particular) or Piritramid (Pheochromocytoma or conditions affecting the consciousness)
• Poor general condition (ECOG Performance Status 3,4; Karnofsky Index < 50%)
• Addictive disorders
• Administration of antidepressive drugs
• Administration of drugs that potentially depress the respiratory function
• Severe cardio-circulatory or respiratory insufficiency, sleep apnea syndrome
• Known bradycardia
• History of syncope(s) of unclear etiology
• Pregnancy or lactation

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Reduction of pain and anxiety during and after the punction procedure
Comparison of the efficacy of the three investigated methods to the placebo group, as well as to the group not receiving any pretreatment at all.

Secondary Outcome Measures

Name	Time	Method
Duration of the effective pain reduction in each of the investigated groups
Assessment of the quality of life in the period immediately after the bone marrow puncture

Trial Locations

Locations (1)

Medizinische Klinik und Poliklinik I, University Clinic Carl Gustav Carus; 🇩🇪 Dresden, Sachsen, Germany